Pharmafile Logo
Pharmafocus logo
Advanced Search

AbbVie

Showing 15 posts of 235 posts found.

Shire image

AbbVie agrees to buy Shire for £32bn

July 18, 2014
Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

News
abbvie image

AbbVie a step closer to Shire takeover

July 14, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

News
Shire image

AbbVie makes fourth Shire offer

July 9, 2014
Sales and Marketing AbbVie, Abbott, Shire, buyout, merger

The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …

News
Shire image

AbbVie spells out Shire benefits

June 26, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger

AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …

News
boehringer image

Boehringer abandons hep C

June 23, 2014
Research and Development, Sales and Marketing AbbVie, Boehringer, HCV, faldaprevir, german, hep C

Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …

News
AbbVie logo

AbbVie moves in on Shire with $46 billion bid

June 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …

News
Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

News
EMA image

EMA changes ‘on screen’ data policy

June 16, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

News
Abbvie image

AbbVie highlights treatment adherence

June 12, 2014
Sales and Marketing ALIGN, AbbVie, Abbott, Crohn’s disease, TNF, ankylosing spondylitis, psoriasis, psoriatic arthritis, rheumatoid arthritis, treatment, ulcerative colitis

Patients with inflammatory diseases tend to be better at following their treatment regimes with TNF inhibitors rather than other medicines, …

News
Abbvie image

AbbVie expands Sligo plant

June 5, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Ireland, Sligo, manufacturing

AbbVie has officially opened its expanded manufacturing plant in Sligo, Ireland. The US company has put €85 million into the …

News
bms_close_logo

BMS and AbbVie get FDA lift

May 21, 2014
Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma

Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …

News
Abbott logo

Abbott makes Latin America move

May 20, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging

Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …

News
Humira image

Humira drives AbbVie again

April 28, 2014
Sales and Marketing AbbVie, Abbott, Humira, RA

Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …

News
ema_building_face_web

EMA transparency agenda sees more delay

April 9, 2014
Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency

The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …

News
Abbvie image

AbbVie drops EMA legal case after compromise

April 4, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026